Our CSO, Glenn Prestwich on Commentary in Science Translational Medicine

Dr. Prestwich, along with other experts in translational medicine presented their views on “What is the Greatest Regulatory Challenge in the Translation of Biomaterials to the Clinic”.

The commentary appeared in the Nov 14, 2012 issue of Science Translational Medicine.
Read the Article

Science Translational Medicine